can you take semaglutide for Weight Loss: How It Works, Comparisons, and More How Long To Take Semaglutide

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

Portion awareness helps you respond to fullness cues: Serving modest amounts first and adding more only if desired helps align breakfast with your body's changing appetite signals

Limitations of the Medicare GLP-1 Bridge Program While the Bridge Program represents meaningful progress, it has important limitations

Brighter, firmer, and healthier-looking skin